Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$24.71
-0.1%
$18.32
$9.30
$24.91
$1.16B1.581.43 million shs1.06 million shs
Liquidia Corporation stock logo
LQDA
Liquidia
$59.30
+3.0%
$39.25
$11.85
$59.75
$5.12B0.411.54 million shs1.58 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$23.83
-0.4%
$26.02
$16.41
$30.42
$3.89B0.923.27 million shs2.95 million shs
Snail, Inc. stock logo
SNAL
Snail
$1.08
+115.1%
$0.63
$0.34
$2.16
$18.97M1.114.74 million shs276.12 million shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.04%+0.00%+70.33%+67.43%+93.92%
Liquidia Corporation stock logo
LQDA
Liquidia
+1.75%+36.66%+48.24%+47.52%+260.16%
Envista Holdings Corporation stock logo
NVST
Envista
-1.45%-11.80%-11.01%-16.69%+27.99%
Snail, Inc. stock logo
SNAL
Snail
-0.08%-7.97%+33.18%-13.58%-55.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$24.71
-0.1%
$18.32
$9.30
$24.91
$1.16B1.581.43 million shs1.06 million shs
Liquidia Corporation stock logo
LQDA
Liquidia
$59.30
+3.0%
$39.25
$11.85
$59.75
$5.12B0.411.54 million shs1.58 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$23.83
-0.4%
$26.02
$16.41
$30.42
$3.89B0.923.27 million shs2.95 million shs
Snail, Inc. stock logo
SNAL
Snail
$1.08
+115.1%
$0.63
$0.34
$2.16
$18.97M1.114.74 million shs276.12 million shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.04%+0.00%+70.33%+67.43%+93.92%
Liquidia Corporation stock logo
LQDA
Liquidia
+1.75%+36.66%+48.24%+47.52%+260.16%
Envista Holdings Corporation stock logo
NVST
Envista
-1.45%-11.80%-11.01%-16.69%+27.99%
Snail, Inc. stock logo
SNAL
Snail
-0.08%-7.97%+33.18%-13.58%-55.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
1.00
SellN/AN/A
Liquidia Corporation stock logo
LQDA
Liquidia
2.92
Moderate Buy$49.33-16.81% Downside
Envista Holdings Corporation stock logo
NVST
Envista
2.40
Hold$28.8321.00% Upside
Snail, Inc. stock logo
SNAL
Snail
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest AVNS, SNAL, LQDA, and NVST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetBuy$55.00 ➝ $67.00
5/12/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetOverweight$51.00 ➝ $62.00
5/11/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Reiterated RatingBuy$60.00
5/11/2026
Envista Holdings Corporation stock logo
NVST
Envista
DowngradeHold (C)Hold (C-)
5/11/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetBuy$54.00 ➝ $70.00
5/11/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetBuy$50.00 ➝ $59.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Reiterated RatingOutperform$33.00
5/7/2026
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
DowngradeHoldStrong Sell
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetNeutral$26.00 ➝ $29.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetOutperform$30.00 ➝ $31.00
5/6/2026
Snail, Inc. stock logo
SNAL
Snail
DowngradeSell (D)Sell (D-)
(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$715.90M1.62$3.42 per share7.22$16.70 per share1.48
Liquidia Corporation stock logo
LQDA
Liquidia
$288.07M18.31N/AN/A$1.22 per share48.61
Envista Holdings Corporation stock logo
NVST
Envista
$2.81B1.38$2.13 per share11.18$18.92 per share1.26
Snail, Inc. stock logo
SNAL
Snail
$81.23M0.50N/AN/A($0.58) per share-1.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$72.90M-$1.61N/A26.56N/A-10.39%5.39%3.97%N/A
Liquidia Corporation stock logo
LQDA
Liquidia
-$68.92M$0.14423.6015.61N/A7.74%46.82%7.06%N/A
Envista Holdings Corporation stock logo
NVST
Envista
$47M$0.4158.1215.281.522.41%7.11%3.91%N/A
Snail, Inc. stock logo
SNAL
Snail
-$27.24M-$0.74N/A3.86N/A-17.79%-12.69%-1.94%N/A

Latest AVNS, SNAL, LQDA, and NVST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
Snail, Inc. stock logo
SNAL
Snail
-$0.21$0.06+$0.27$0.05$18.00 million$26.90 million
5/11/2026Q1 2026
Liquidia Corporation stock logo
LQDA
Liquidia
$0.4102$0.52+$0.1098$0.52$119.44 million$132.87 million
5/6/2026Q1 2026
Envista Holdings Corporation stock logo
NVST
Envista
$0.31$0.36+$0.05$0.23$680.04 million$705.50 million
5/5/2026Q1 2026
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.16$0.22+$0.06$0.11$170.00 million$182.20 million
3/19/2026Q4 2025
Snail, Inc. stock logo
SNAL
Snail
-$0.04-$0.03+$0.01-$0.03$23.00 million$20.80 million
3/18/2026Q4 2025
Liquidia Corporation stock logo
LQDA
Liquidia
$0.01$0.15+$0.14N/AN/AN/A
3/5/2026Q4 2025
Liquidia Corporation stock logo
LQDA
Liquidia
$0.08$0.15+$0.07$0.15$87.49 million$92.02 million
2/24/2026Q4 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.24$0.29+$0.05-$0.03$174.70 million$180.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Liquidia Corporation stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
Snail, Inc. stock logo
SNAL
Snail
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.11
2.48
1.40
Liquidia Corporation stock logo
LQDA
Liquidia
1.18
2.22
1.84
Envista Holdings Corporation stock logo
NVST
Envista
0.47
2.44
2.06
Snail, Inc. stock logo
SNAL
Snail
N/A
0.62
0.62

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Liquidia Corporation stock logo
LQDA
Liquidia
64.54%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
Snail, Inc. stock logo
SNAL
Snail
0.36%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.33%
Liquidia Corporation stock logo
LQDA
Liquidia
25.60%
Envista Holdings Corporation stock logo
NVST
Envista
0.99%
Snail, Inc. stock logo
SNAL
Snail
68.32%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2,28746.83 million45.73 millionOptionable
Liquidia Corporation stock logo
LQDA
Liquidia
5088.93 million66.14 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,000162.73 million161.12 millionOptionable
Snail, Inc. stock logo
SNAL
Snail
6037.78 million11.97 millionNot Optionable

Recent News About These Companies

Snail, Inc. (SNAL) Q1 2026 Earnings Call Transcript
Snail (SNAL) Q1 2026 Earnings Call Transcript
Snail posts 36% revenue jump as ARK franchise drives return to profit
Snail, Inc. Reports First Quarter 2026 Financial Results
Snail (SNAL) Projected to Post Quarterly Earnings on Wednesday
In Fenglin, snails set the pace

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$24.70 -0.02 (-0.06%)
Closing price 03:59 PM Eastern
Extended Trading
$24.70 0.00 (0.00%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Liquidia stock logo

Liquidia NASDAQ:LQDA

$59.30 +1.71 (+2.97%)
Closing price 04:00 PM Eastern
Extended Trading
$58.08 -1.22 (-2.06%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Envista stock logo

Envista NYSE:NVST

$23.83 -0.09 (-0.38%)
Closing price 03:59 PM Eastern
Extended Trading
$23.85 +0.02 (+0.08%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Snail stock logo

Snail NASDAQ:SNAL

$1.08 +0.58 (+115.10%)
Closing price 04:00 PM Eastern
Extended Trading
$1.13 +0.05 (+4.91%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Snail, Inc., together with its subsidiaries, researches, develops, markets, publishes, and distributes interactive digital entertainment for consumers worldwide. It offers games, content, and support for various platforms, including game consoles, personal computers, mobile phones, and tablets. Snail, Inc. was founded in 2009 and is headquartered in Culver City, California. Snail, Inc. operates as a subsidiary of Olive Wood Global Development Limited.